Global and Region Human DNA Vaccines Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of Human DNA Vaccines market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Human DNA Vaccinesmarket, defines the market attractiveness level of Human DNA Vaccines market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Human DNA Vaccines industry, describes the types of Human DNA Vaccines market, the applications of major players and the market size, and deeply analyzes the current situation of the global Human DNA Vaccines market and the development prospects and opportunities of Human DNA Vaccines industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Human DNA Vaccines market in Chapter 13.

    By Player:

    • Pharos Biologicals

    • CureVac

    • Astellas Pharma

    • Immunomic Therapeutics

    • Hoffmann-La Roche

    • MedImmune

    • GeneOne Life Science

    • Sanofi

    • Inovio Pharmaceuticals

    • Boehringer Ingelheim

    By Type:

    • Recombinant Protein Vaccine

    • Gene-based Vaccine

    By End-User:

    • Influenza

    • Human Papillomavirus

    • HIV

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Human DNA Vaccines Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Human DNA Vaccines Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Human DNA Vaccines Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Human DNA Vaccines Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Human DNA Vaccines Market Analysis and Outlook to 2022

    • 7.1 Global Human DNA Vaccines Consumption (2017-2022)

    • 7.2 United States Human DNA Vaccines Consumption (2017-2022)

    • 7.3 Europe Human DNA Vaccines Consumption (2017-2022)

    • 7.4 China Human DNA Vaccines Consumption (2017-2022)

    • 7.5 Japan Human DNA Vaccines Consumption (2017-2022)

    • 7.6 India Human DNA Vaccines Consumption (2017-2022)

    • 7.7 South Korea Human DNA Vaccines Consumption (2017-2022)

    8 Region and Country-wise Human DNA Vaccines Market Analysis and Outlook to 2028

    • 8.1 Global Human DNA Vaccines Consumption Forecast (2022-2028)

    • 8.2 United States Human DNA Vaccines Consumption Forecast (2022-2028)

    • 8.3 Europe Human DNA Vaccines Consumption Forecast (2022-2028)

    • 8.4 China Human DNA Vaccines Consumption Forecast (2022-2028)

    • 8.5 Japan Human DNA Vaccines Consumption Forecast (2022-2028)

    • 8.6 India Human DNA Vaccines Consumption Forecast (2022-2028)

    • 8.7 South Korea Human DNA Vaccines Consumption Forecast (2022-2028)

    9 Global Human DNA Vaccines Market Outlook by Types and Applications to 2022

    • 9.1 Global Human DNA Vaccines Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Gene-based Vaccine Consumption and Growth Rate (2017-2022)

    • 9.2 Global Human DNA Vaccines Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Influenza Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Human Papillomavirus Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global HIV Consumption and Growth Rate (2017-2022)

    10 Global Human DNA Vaccines Market Outlook by Types and Applications to 2028

    • 10.1 Global Human DNA Vaccines Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Gene-based Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Human DNA Vaccines Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Influenza Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Human Papillomavirus Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global HIV Consumption Forecast and Growth Rate (2022-2028)

    11 Global Human DNA Vaccines Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Human DNA Vaccines Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Human DNA Vaccines Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Human DNA Vaccines Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Human DNA Vaccines Market Competitive Analysis

    • 14.1 Pharos Biologicals

      • 14.1.1 Pharos Biologicals Company Details

      • 14.1.2 Pharos Biologicals Human DNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Pharos Biologicals Human DNA Vaccines Product and Service

    • 14.2 CureVac

      • 14.2.1 CureVac Company Details

      • 14.2.2 CureVac Human DNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 CureVac Human DNA Vaccines Product and Service

    • 14.3 Astellas Pharma

      • 14.3.1 Astellas Pharma Company Details

      • 14.3.2 Astellas Pharma Human DNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Astellas Pharma Human DNA Vaccines Product and Service

    • 14.4 Immunomic Therapeutics

      • 14.4.1 Immunomic Therapeutics Company Details

      • 14.4.2 Immunomic Therapeutics Human DNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Immunomic Therapeutics Human DNA Vaccines Product and Service

    • 14.5 Hoffmann-La Roche

      • 14.5.1 Hoffmann-La Roche Company Details

      • 14.5.2 Hoffmann-La Roche Human DNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Hoffmann-La Roche Human DNA Vaccines Product and Service

    • 14.6 MedImmune

      • 14.6.1 MedImmune Company Details

      • 14.6.2 MedImmune Human DNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 MedImmune Human DNA Vaccines Product and Service

    • 14.7 GeneOne Life Science

      • 14.7.1 GeneOne Life Science Company Details

      • 14.7.2 GeneOne Life Science Human DNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 GeneOne Life Science Human DNA Vaccines Product and Service

    • 14.8 Sanofi

      • 14.8.1 Sanofi Company Details

      • 14.8.2 Sanofi Human DNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Sanofi Human DNA Vaccines Product and Service

    • 14.9 Inovio Pharmaceuticals

      • 14.9.1 Inovio Pharmaceuticals Company Details

      • 14.9.2 Inovio Pharmaceuticals Human DNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Inovio Pharmaceuticals Human DNA Vaccines Product and Service

    • 14.10 Boehringer Ingelheim

      • 14.10.1 Boehringer Ingelheim Company Details

      • 14.10.2 Boehringer Ingelheim Human DNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Boehringer Ingelheim Human DNA Vaccines Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Human DNA Vaccines

    • Figure Human DNA Vaccines Picture

    • Table Global Human DNA Vaccines Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Human DNA Vaccines Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Human DNA Vaccines Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Human DNA Vaccines Consumption by Country (2017-2022)

    • Figure United States Human DNA Vaccines Consumption and Growth Rate (2017-2022)

    • Table Europe Human DNA Vaccines Consumption and Growth Rate (2017-2022)

    • Figure China Human DNA Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Japan Human DNA Vaccines Consumption and Growth Rate (2017-2022)

    • Figure India Human DNA Vaccines Consumption and Growth Rate (2017-2022)

    • Figure South Korea Human DNA Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Human DNA Vaccines Consumption Forecast by Country (2022-2028)

    • Figure United States Human DNA Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Human DNA Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Human DNA Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Human DNA Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Human DNA Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Human DNA Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global Gene-based Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global Influenza Consumption and Growth Rate (2017-2022)

    • Figure Global Human Papillomavirus Consumption and Growth Rate (2017-2022)

    • Figure Global HIV Consumption and Growth Rate (2017-2022)

    • Figure Global Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gene-based Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Influenza Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Human Papillomavirus Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global HIV Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Human DNA Vaccines Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Human DNA Vaccines Export by Region (Top 5 Countries) (2017-2028)

    • Table Pharos Biologicals (Foundation Year, Company Profile and etc.)

    • Table Pharos Biologicals Human DNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pharos Biologicals Human DNA Vaccines Product and Service

    • Table CureVac (Foundation Year, Company Profile and etc.)

    • Table CureVac Human DNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table CureVac Human DNA Vaccines Product and Service

    • Table Astellas Pharma (Foundation Year, Company Profile and etc.)

    • Table Astellas Pharma Human DNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Pharma Human DNA Vaccines Product and Service

    • Table Immunomic Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Immunomic Therapeutics Human DNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Immunomic Therapeutics Human DNA Vaccines Product and Service

    • Table Hoffmann-La Roche (Foundation Year, Company Profile and etc.)

    • Table Hoffmann-La Roche Human DNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hoffmann-La Roche Human DNA Vaccines Product and Service

    • Table MedImmune (Foundation Year, Company Profile and etc.)

    • Table MedImmune Human DNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table MedImmune Human DNA Vaccines Product and Service

    • Table GeneOne Life Science (Foundation Year, Company Profile and etc.)

    • Table GeneOne Life Science Human DNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table GeneOne Life Science Human DNA Vaccines Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Human DNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Human DNA Vaccines Product and Service

    • Table Inovio Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Inovio Pharmaceuticals Human DNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Inovio Pharmaceuticals Human DNA Vaccines Product and Service

    • Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim Human DNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim Human DNA Vaccines Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.